| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/07/1994 | CA1330038C Methods and compositions for the use of hiv env polypeptides and antibodies thereto |
| 06/05/1994 | CA2107694A1 Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization |
| 06/05/1994 | CA2102551A1 Use of ionic cloud point modifiers to prevent particle aggregation during sterilization |
| 06/03/1994 | CA2107280A1 Preparation and magnetic properties of very small magnetite-dextran particles |
| 06/01/1994 | EP0599819A2 Additives enhancing topical actions of therapeutic agents |
| 06/01/1994 | EP0599543A1 Pharmaceutical preparation comprising fat emulsion of fat microparticles |
| 06/01/1994 | EP0599303A2 Peptide conjugate |
| 06/01/1994 | EP0599274A1 HER4, a human receptor tyrosine kinase of the epidermal growth factor receptor family |
| 06/01/1994 | EP0599262A2 Stabilized superoxide-dismutase (SOD) compositions |
| 06/01/1994 | EP0599142A2 Method for making immuno-conjugates |
| 06/01/1994 | EP0599064A1 Retard form for pharmaceutically active agents |
| 06/01/1994 | EP0598905A1 STABILIZED IL-1$g(a) PHARMACEUTICAL PREPARATION |
| 06/01/1994 | EP0598818A1 Escherichia coli o-polysaccharide-protein conjugate vaccine |
| 06/01/1994 | EP0598719A1 Receptor conjugates for targeting drugs and other agents |
| 06/01/1994 | EP0577646A4 Sustained release drug delivery devices |
| 06/01/1994 | EP0523120B1 Film-forming product intended for coating solid forms |
| 06/01/1994 | EP0514544B1 Immune complexes |
| 06/01/1994 | EP0321481B1 Microgranular preparation useful in the delivery of biologically active materials to the intestinal regions of animals |
| 06/01/1994 | CN1087262A Controlied release oxycodone compositions |
| 06/01/1994 | CN1024754C Antibacterial lyophilized prepn. |
| 06/01/1994 | CN1024753C Method for preparing contraceptive implant |
| 05/31/1994 | US5317097 DNA oligomers and genetic engineering |
| 05/31/1994 | US5317079 Fatty acid terminated polyanhydride |
| 05/31/1994 | US5317065 Poly amino dicarboxylic acid-co-anhydro amino dicarboxylic acid derivative |
| 05/31/1994 | US5317009 Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
| 05/31/1994 | US5316937 Conditioned medium useful for sustaining growth of colonic crypt cells |
| 05/31/1994 | US5316921 Which are resistant to proteolytic cleavage by enzymes capable of in vivo conversion of hgf into it's two chain form |
| 05/31/1994 | US5316774 Blocked polymeric particles having internal pore networks for delivering active substances to selected environments |
| 05/31/1994 | US5316773 Solid preparation of 3-(3-(6-benzoyloxy-3-cyano-2-pyridyloxy-carbonyl)-benzoyl)-1-ethoxymethyl-5 -fluorouracil having enhanced water solubility |
| 05/31/1994 | US5316761 Cosmetic gel stick compositions |
| 05/31/1994 | US5316759 Agonist-antagonist combination to reduce the use of nicotine and other drugs |
| 05/28/1994 | CA2110087A1 Stabilised superoxide dismutase (sod) composition |
| 05/28/1994 | CA2110086A1 Peptide conjugate |
| 05/26/1994 | WO1994011535A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 05/26/1994 | WO1994011508A2 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
| 05/26/1994 | WO1994011497A1 Method of causing selective immunosuppression using hl-60-related lectins |
| 05/26/1994 | WO1994011399A1 Specifically crosslinked hemoglobin with free functionality |
| 05/26/1994 | WO1994011032A1 Restrained multifunctional reagent for surface modification |
| 05/26/1994 | WO1994011031A1 Enclosure compound manufacturing method |
| 05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | WO1994011017A1 Orally administrable preparation |
| 05/26/1994 | WO1994011015A1 Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design |
| 05/26/1994 | WO1994011003A1 Cancerous b cell treatment using substituted nucleoside derivatives |
| 05/26/1994 | WO1994010999A1 Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system |
| 05/26/1994 | WO1994010986A1 Transdermal delivery of ketorolac |
| 05/26/1994 | WO1994010984A1 TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF 17-β-ESTRADIOL AND PROCESS FOR ITS PRODUCTION |
| 05/26/1994 | WO1994010980A1 Compositions using microencapsulated neutralizing antibodies |
| 05/26/1994 | WO1994010978A1 Method for the preparation of creams |
| 05/26/1994 | WO1994008624A3 Therapeutic and diagnostic imaging compositions and methods |
| 05/26/1994 | WO1994008571A3 Plaster for the transdermal administration of volatile, pharmaceutically active, chemically alkaline ingredients, and processs for producing the same |
| 05/26/1994 | DE4238223C1 Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung Transdermal therapeutic system for the administration of physostigmine to the skin, and process for its preparation |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149132A1 Specifically crosslinked hemoglobin with free functionality |
| 05/25/1994 | EP0598606A1 Extrudable compositions for topical or transdermal drug delivery |
| 05/25/1994 | EP0598309A2 Multilayer matrix systems for the controlled release of active principles |
| 05/25/1994 | EP0598037A1 Buffered formulation of peg-sod |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0476063B1 Glucan drug delivery system and adjuvant |
| 05/25/1994 | EP0357793B1 Suspended-release preparation prepared by using alginates |
| 05/25/1994 | CA2109636A1 Process for preparing immunoconjugates |
| 05/25/1994 | CA2103323A1 Her4 human receptor tyrosine kinase |
| 05/24/1994 | USRE34618 Solution with polyhydric alcohol; storage stability |
| 05/24/1994 | USRE34617 An edible, nonabsorbable, indigestible liquid sugar esterified by a fatty acid, a diarrhea prevention agent and fat-soluble vitamins; anticholesterol and lipemic agents; cooking shortenings |
| 05/24/1994 | US5314995 Antitumor |
| 05/24/1994 | US5314921 Vehicle for oral administered drugs |
| 05/24/1994 | US5314872 Glucan sulfate, stabilized fibroblast growth factor composition |
| 05/24/1994 | US5314817 Catalytic and reactive polypeptides and methods for their preparation and use |
| 05/24/1994 | US5314813 Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines |
| 05/24/1994 | US5314694 Transdermal formulations, methods and devices |
| 05/24/1994 | US5314642 Hydrolysis |
| 05/24/1994 | CA1329854C Biodegradable polymeric materials based on polyether glycols, processes for the preparation thereof and surgical articles made therefrom |
| 05/24/1994 | CA1329767C Controlled and delayed release oral pharmaceutical composition |
| 05/24/1994 | CA1329764C Pharmaceutical compositions |
| 05/24/1994 | CA1329763C Stabilized fgf composition and production thereof |
| 05/24/1994 | CA1329760C Plasma and recombinant protein formulations in high ionic strength media |
| 05/18/1994 | EP0597414A2 Stable formulation of Senna extract |
| 05/18/1994 | EP0597340A1 Medication for skin diseases |
| 05/18/1994 | EP0597101A1 Stabilized human monoclonal antibody preparation |
| 05/18/1994 | EP0597036A1 Microencapsulated quaternary ammonium compounds |
| 05/18/1994 | EP0597007A1 W/o microemulsions. |
| 05/18/1994 | EP0596984A1 Preparation of microparticles |
| 05/18/1994 | EP0596953A1 Emulsifier concentrates |
| 05/18/1994 | EP0583413A4 Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide |
| 05/18/1994 | EP0537139B1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced |
| 05/18/1994 | EP0516749B1 Immobilized polyethylene oxide star molecules for bioapplications |
| 05/18/1994 | CN1086740A Composition based on absorbable precipitate SiO2 |
| 05/18/1994 | CN1086728A Red ginseng and tuber of dwarf lily turf powder injection and its preparing method |
| 05/18/1994 | CN1086708A Memanting-containing solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 05/18/1994 | CN1024557C Process for composition containing associated compound of hyaluronic acid |
| 05/17/1994 | US5312834 Eicosapentenoic acid, a-linolenic acid |
| 05/17/1994 | US5312819 Schizophrenia |
| 05/17/1994 | US5312808 Polyoxyethylene glycol conjugates with hemoglobin |
| 05/17/1994 | US5312751 Hybridoma producing a monoclonal antibody specific for an antigen of the stratum corneum of human epidermis |
| 05/17/1994 | US5312629 Method for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases |
| 05/17/1994 | US5312627 Transdermal therapeutic system for the administration of drugs having bronchodilating activity |
| 05/17/1994 | US5312626 Lozenge or chewable tablet |
| 05/17/1994 | US5312616 Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract |
| 05/17/1994 | CA1329678C Preparation of finely divided pulverulent crosslinked copolymers |
| 05/17/1994 | CA1329549C Microparticles containing an antimalarial active ingredient |
| 05/17/1994 | CA1329547C Skin permeation enhancer compositions using glycerol monooleate |